Susan Solinsky

HIP - is an opportunistic venture capital firm that uses a unique multi-disciplinary collaborative ecosystem model to fund innovation in healthcare. A firm with a TRUE NORTH of conducting the most detailed and complete early stage diligence in the industry - HIP has grown to over 275 investors (including 90 institutional including 18 health system strategic investors). HIP endorses an opportunity for investment ONLY after its extensive diligence and deploys capital through its Fund and sidecar - deal by deal investment vehicle. In parallel - institutional investors in HIP deploy capital through their own structures and funds based on their independent decision but heavily weighed by the collective HIP endorsement and powerful HIP model/process. As of late 2024 - HIP portfolio has 12 early stage healthcare technology companies. With over 75% having received multiple rounds of funding from the HIP ecosystem. Visit our site for details to join our mission as an investor in healthcare or to seek audience for investment (fill out a short sign up form)

We are a diverse, partner-minded investment firm focused on technology and tech-enabled businesses that have established market fit and are looking for more than just capital for the next phase of growth. We leverage thoughtfully structured solutions and invest behind thematic areas identified from 15+ years of experience. Our team has managed over $1B of AUM across more than 50 platform investments.

Kayne Anderson, founded in 1984, is a leading alternative investment management firm focused on real estate, credit, infrastructure, and energy. With a team defined by an entrepreneurial and resilient culture, Kayne Anderson’s investment philosophy is to pursue cash flow-oriented niche strategies where knowledge and sourcing advantages enable us to deliver above average, risk-adjusted investment returns. Kayne manages $38 billion in assets (as of 3/31/2025) for institutional investors, family offices, high net worth and retail clients and employs 350 professionals.

Coyote Ventures invests in tech-enabled solutions that drive access to healthcare for overlooked populations, with a foundation in women’s health. Founded by scientists, entrepreneurs, and investors, Coyote takes an integrative view of health that spans physical, financial, and emotional health. We host biannual Health Equity Innovators gatherings - learn more here: https://www.healthequityinnovators.com/ Founders: we have a form on our website for funding submissions. https://www.coyote.ventures/

HIP - is an opportunistic venture capital firm that uses a unique multi-disciplinary collaborative ecosystem model to fund innovation in healthcare. A firm with a TRUE NORTH of conducting the most detailed and complete early stage diligence in the industry - HIP has grown to over 275 investors (including 90 institutional including 18 health system strategic investors). HIP endorses an opportunity for investment ONLY after its extensive diligence and deploys capital through its Fund and sidecar - deal by deal investment vehicle. In parallel - institutional investors in HIP deploy capital through their own structures and funds based on their independent decision but heavily weighed by the collective HIP endorsement and powerful HIP model/process. As of late 2024 - HIP portfolio has 12 early stage healthcare technology companies. With over 75% having received multiple rounds of funding from the HIP ecosystem. Visit our site for details to join our mission as an investor in healthcare or to seek audience for investment (fill out a short sign up form)

DigitalDx Ventures is a majority woman-owned impact fund on a mission to transform global healthcare through early, accurate, and accessible diagnosis. We invest at the intersection of AI, big data, and medical innovation to address some of the world’s most pressing health challenges — including breast and other cancers, cardiovascular and kidney diseases, Alzheimer’s, and mental health. Our team brings together successful Silicon Valley digital health investors, as well as leading medical and legal experts, to identify and support groundbreaking technologies that: Enable earlier, more precise detection Minimize invasiveness in diagnosis and treatment Lower costs and expand access to care At DigitalDx, we believe that smarter diagnostics save lives. By backing bold entrepreneurs and next-generation platforms, we aim to improve health outcomes for millions — while delivering meaningful returns and measurable impact.